How is Atezolizumab dosed?
The dosage of Atezolizumab varies depending on the specific condition being treated, patient's weight, and other factors. The dosage and administration instructions are provided by a healthcare professional and may vary based on individual circumstances.
For non-small cell lung cancer, the starting dose is typically 1200 mg administered by intravenous infusion every 3 weeks. The dose may be adjusted based on the patient's response to treatment and any side effects experienced.
In small cell lung cancer, atezolizumab is given in combination with other medications, and the dosage is determined by the other medications in the regimen.
For liver cancer and melanoma, the dosage may also vary depending on the patient's condition and other medications being used. It is important to follow the dosage instructions provided by your healthcare professional.
What is the dosage form of Atezolizumab?
The dosage form of Atezolizumab is a solution for intravenous administration.
How is Atezolizumab administered?
Atezolizumab is administered through an intravenous injection given by a healthcare professional. It is typically given in a healthcare setting such as a hospital or clinic. The injection can be given through a vein in your arm or other suitable location as determined by your healthcare provider. The solution form of Atezolizumab is used for this intravenous administration.
What are common precautions when taking Atezolizumab?
Common precautions when taking Atezolizumab include:
- Informing your healthcare professional of any allergies to this medicine or other medications, foods, dyes, preservatives, or animals.
- Reporting any unusual or allergic reactions to your healthcare professional immediately.
- Discussing the risks and benefits of using this medicine with your doctor, especially if you are pregnant, breastfeeding, or planning to become pregnant.
- Informing your healthcare professional if you have any medical conditions, especially liver or kidney problems, before starting treatment.
- Adhering to your healthcare professional's instructions regarding dosage and frequency of administration.
- Reporting any side effects, including those not listed, to your healthcare professional immediately.
- Avoiding the use of this medicine if you are allergic to it or any of its components.
- Being aware that this medicine is only to be given by or under the supervision of your doctor.
- Being aware that appropriate studies have not been performed on the relationship of age to the effects of Atezolizumab injection in the pediatric population, and its safety and efficacy have not been established.